Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
13F holders, Q1 2024
Institutional positions in Cero Therapeutics Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −2 vs. Q4 2023
- Shares held
- 4.77M
- −222.5K (−4.5%) vs. Q4 2023
- Total value
- $425.3K
- +$290.3K (+214.9%) vs. Q4 2023
- New holders
- 6
- 4 more added
- Sold out
- 8
- 9 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CEROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $22 |
| Q3 2025 | 22 | $38.1K |
| Q2 2025 | 23 | $74.5K |
| Q1 2025 | 26 | $45.7K |
| Q4 2024 | 27 | $28.6K |
| Q3 2024 | 31 | $28.0K |
| Q2 2024 | 35 | $110.3K |
| Q1 2024 | 38 | $425.3K |
| Q4 2023 | 41 | $135.1K |
| Q3 2023 | 44 | $423.7K |
| Q2 2023 | 44 | $351.0K |
| Q1 2023 | 47 | $234.9K |
| Q4 2022 | 50 | $264.8K |
| Q3 2022 | 44 | $503.0K |
| Q2 2022 | 42 | $550.0K |
| Q1 2022 | 36 | $1.02M |
| Q4 2021 | 31 | $1.35M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Highbridge Capital Management LLC | – | $73.7K | 0.00% | – | – |
| Cowen and Company, LLC | 638,601 | $43.6K | 0.00% | +438,511+219.2% | Added |
| Periscope Capital Inc. | 591,500 | $40.3K | 0.01% | −365,598−38.2% | Reduced |
| Atalaya Capital Management LP | 425,000 | $37.8K | 0.04% | +200,000+88.9% | Added |
| Cantor Fitzgerald, L. P. | 441,048 | $35.2K | 0.01% | +77,500+21.3% | Added |
| Saba Capital Management, L.P. | 295,913 | $26.3K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 375,000 | $25.6K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 249,999 | $20.0K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 268,129 | $18.3K | 0.00% | +268,129 | New |
| Shaolin Capital Management LLC | 267,599 | $18.3K | 0.00% | −23,400−8.0% | Reduced |
| Q Global Advisors, LLC | 170,785 | $12.0K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 143,925 | $9.82K | 0.00% | +2,883+2.0% | Added |
| Context Capital Management, LLC | 122,013 | $8.32K | 0.00% | −77,987−39.0% | Reduced |
| Highland Capital Management Fund Advisors, L.P. | 108,741 | $7.42K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 74,998 | $6.67K | 0.00% | 00.0% | Unchanged |
| Ionic Capital Management LLC | 80,300 | $5.48K | 0.00% | +80,300 | New |
| Picton Mahoney Asset Management | 75,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 64,113 | $4.37K | 0.00% | −23,780−27.1% | Reduced |
| Yakira Capital Management, Inc. | 49,999 | $3.41K | 0.00% | 00.0% | Unchanged |
| Kim, LLC | 50,000 | $3.41K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 50,000 | $3.41K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 36,000 | $3.00K | 0.00% | −296−0.8% | Reduced |
| Rivernorth Capital Management, LLC | 24,998 | $1.75K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 25,000 | $1.71K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 23,968 | $1.64K | 0.00% | −2,050−7.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 20,000 | $1.36K | 0.00% | −13,373−40.1% | Reduced |
| Susquehanna International Group, LLP | 13,945 | $1.24K | 0.00% | +13,945 | New |
| DuPont Capital Management Corp | 12,500 | $1.11K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 12,500 | $1.11K | 0.00% | 00.0% | Unchanged |
| Flow Traders U.S. LLC | 17,967 | $1.00K | 0.00% | −9,753−35.2% | Reduced |
| Walleye Trading LLC | 13,482 | $919 | 0.00% | 00.0% | Unchanged |
| Silver Rock Financial LP | 12,224 | $834 | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,500 | $716 | 0.00% | −6,240−37.3% | Reduced |
| Exos Asset Management LLC | 3,700 | $252 | 0.00% | +3,700 | New |
| Ancora Advisors, LLC | 2,500 | $170 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 200 | $14 | 0.00% | 00.0% | Unchanged |
| Pineridge Advisors LLC | 150 | $10 | 0.00% | +150 | New |
| Tower Research Capital LLC (TRC) | 87 | $6 | 0.00% | +87 | New |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −246,696−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −149,380−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −43,673−100.0% | Sold out |
| Spartan Fund Management Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −14,502−100.0% | Sold out |
| Robinson Capital Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Segantii Capital Management Ltd | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Exos TFP Holdings LLC | – | – | – | – | Not filed |